Press Releases
CHESTERFIELD, Mo., March 27, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2019.
Read more...WAYNE, Pa., March 27, 2020 /PRNewswire/ -- Zyla Life Sciences (OTCQX: ZCOR) ("Zyla" or the "Company"), a commercial-stage life sciences company, today reported financial results for the fourth quarter and full year ended December 31, 2019, including net sales from commercial products: SPRIX® (ketorolac tromethamine)
Read more...27 March 2020
SHANGHAI, March 27, 2020 /PRNewswire/ -- Luye Pharma Group (02186.HK) reported its financial results for 2019 on March 27, 2020. According to the results, the company has achieved a total revenue of RMB 6.358 billion, up 22.9% year-on-year. EBITDA was RMB 2.488 billion, up 26.
Read more...STOCKHOLM, March 27, 2020 /PRNewswire/ -- The shareholders in Moberg Pharma AB (publ) (reg. no. 556697-7426) (the "Company" or "Moberg Pharma") are hereby convened to the Extraordinary General Meeting on Tuesday, 28 April 2020 at 4:30 p.m. (CET) in the Company's premises in Bromma, address Gustavslunds
Read more...27 March 2020
OSLO, Norway, March 27, 2020 /PRNewswire/ -- On 26 March 2020, the Board of Directors of Nordic Nanovector ASA approved the company's financial statements for 2019. The company's 2019 Annual Report is attached and available on Nordic Nanovector ASA's website:
Read more...27 March 2020
STOCKHOLM, March 27, 2020 /PRNewswire/ -- SyntheticMR announced today that they have received a purchase order from Mayo Clinic for its medical imaging software solution SyMRI.Mayo Clinic is ranked the No. 1 hospital in the US and receives more than 1.2 million patients from all 50 states. The purchase order relates to SyntheticMR's product SyMRI for use i
Read more...SUZHOU, China, March 27, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has submitted a New Drug Application (NDA) to the Taiwan Food and Drug Administration (TFDA) for avapritinib, a precision therapy being developed for the treatment of gastrointestinal stromal tumor (GIST), and had received priorit
Read more...27 March 2020
MOUNTAIN VIEW, Calif., March 27, 2020 /PRNewswire/ -- The cost of healthcare is still a factor for many Americans during the Coronavirus pandemic. A recent healthinsurance.com
Read more...26 March 2020
Shenzhen, China, March 26, 2020 /PRNewswire/ -- Threatened by the novel coronavirus (COVID-19) epidemic, the whole world is in urgent need of medical supplies to take preventive measures and to diagnose patients who have contracted the virus. Eleven board members of Peking University HSBC Business School (PHBS) UK Campus shipped 10,0
Read more...26 March 2020
SILVER SPRING, Md., March 26, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA issued guidance today on a
Read more...